Turning art to science: A focus on lung cancer

The fine art of representing complex science in illustrations and images can often be tasking to the most adept artists and designers. First there is the brainstorming process, then the pages and pages of sketches and templates, and then the small matter of aligning those thoughts and ideas with those of the editor.

This is a situation very familiar to UK illustrator, Russell Cobb, whose work has been much coveted by national publications and featured across the world. Cobb, this month, took on the challenge of designing the front cover of the Nature Outlook on lung cancer working alongside supplement editor, Herb Brody and the Outlook team.

Here Cobb and Brody talk through how their initial designs and thoughts evolved into the final cover seen below. Read the full Outlook supported by Cancer Research UK and Boehringer Ingelheim here.

Continue reading

The Dominant Malignancy: Lung Cancer

Lung cancer is the leading cause of cancer mortality. In some countries, incidence rates are dropping but survival rates for those with the disease remain low.

A special supplement published in Nature today explores the current risks, therapies and causes of lung cancer.

The Nature Outlook on lung cancer, supported by Cancer Research UK and Boehringer Ingelheim, contains commentaries, features and articles on topics including: the risks and costs associated with lung-cancer screening, therapies targeted at the specific genetics of a patient’s lung cancer, air pollution risks and key lung-cancer mutations in non-smokers.

Here is a snapshot of the striking graphics that can be found in the supplement.

For more graphics, features and information, click through to read the free-to-access Outlook.

Continue reading

The big issues affecting lung cancer worldwide

This blog has been produced in collaboration with Cancer Research UK.

Lung cancer is the biggest cancer killer – both here in the UK and globally.

And although the UK has seen signs of improvement – lung cancer rates in men have dropped by 50 per cent in the last four decades – a huge burden still looms. Over the last 40 years, the number of women being diagnosed with the disease has increased by 75 per cent, largely mirroring trends in smoking from decades ago.

To highlight this continuing challenge, Cancer Research UK has teamed up with Nature, which today publishes a series of articles that touch on some key areas for lung cancer – from research to prevention – from across the globe.

Here’s a summary of what to expect from the Nature Outlook on lung cancer.

The dominant malignancy

In the first article, Eric Bender explores global statistics for lung cancer, including the impact of smoking in the UK, and the worrying rise in men smoking in China. Cancer Research UK’s graphic below shows how lung cancer rates follow the pattern of smoking rates in the UK.

Read more

 

Risk factors: Estimated causes of lung cancer in Britain, 2014. Most cases of lung cancer are attributable to smoking, and so could be prevented.

Risk factors: Estimated causes of lung cancer in Britain, 2014. Most cases of lung cancer are attributable to smoking, and so could be prevented.

Continue reading